JE Eckel-Passow, CM Lohse, Y Sheinin, PL Crispen… - Diagnostic …, 2010 - Springer
Abstract Background Although tissue microarrays (TMAs) are commonly employed in clinical and basic-science research, there are no guidelines for evaluating the appropriateness of a …
M Mascolo, G Ilardi, F Merolla, D Russo… - International journal of …, 2012 - mdpi.com
In this study we aimed to confirm the emerging role of Chromatin Assembly Factor 1 (CAF-1 p60) as a new proliferation and prognostic marker for cancer and to test the usefulness of …
FO Buishand, J Visser, M Kik, A Gröne, RI Keesler… - The Veterinary …, 2014 - Elsevier
Tissue microarray (TMA) technology allows analysis of multiple tumour samples simultaneously on a single slide. The aim of the present study was to develop and assess a …
U Ciesielska, A Piotrowska, C Kobierzycki… - in vivo, 2020 - iv.iiarjournals.org
Background/Aim: Comparison of the expression of Ki-67, MCM3, 5, 7 and MTI/II proteins using immunohistochemistry (IHC) on whole section (WS) and tissue microarray (TMA) of …
KS Cunha, AC Caruso, PA Faria, LE SILVA… - Anais da Academia …, 2013 - SciELO Brasil
ABSTRACT AIMS To study the expression of Bcl-2, Bcl-x, as well the presence of cleaved caspase-3 in neurofibromas and malignant peripheral nerve sheath tumors. The expression …
RE Rozza-de-Menezes, LM Almeida… - American Journal of …, 2021 - academic.oup.com
Objectives To evaluate the expression of progesterone receptor (PR), estrogen receptor (ER), and G protein–coupled estrogen receptor 1 (GPER-1) in cutaneous neurofibromas …
Ł Kuźbicki, AA Brożyna - Journal of Cutaneous Pathology, 2020 - Wiley Online Library
Abstract Increased cyclooxygenase‐2 (COX‐2) expression is thought to support tumorigenesis through various mechanisms and is analyzed as a potential cancer marker. In …
Background Multiple cutaneous neurofibromas are a hallmark of neurofibromatosis 1 (NF1). They begin to appear during puberty and increase in number and volume during pregnancy …